VBP
PPRS scheme payment percentage to rise by 6.62% in 2015
December 12, 2014Sales and Marketing ABPI, PPRS, VBP, Whitehead, government, medicines bill
The amount of payment due from pharma via the PPRS scheme for next year has been confirmed by the Department …
Government gets £74m rebate from pharma
June 30, 2014Sales and Marketing ABPI, Hunt, NHS, PPRS, VBP, emms, pricing
The UK government has received a £74 million refund from the pharma industry after it was deemed to have spent …
NICE chair: pharma must show how it prices drugs
April 28, 2014Research and Development, Sales and Marketing Goldacre, Haslam, NICE, VBP, all trials, pars
The pharmaceutical industry must be willing to show the public how it prices its drugs – or face losing its …
Boehringer: ‘devil in detail’ on new drug pricing policy
April 10, 2014Medical Communications, Sales and Marketing Boehringer, PPRS, VBP, Zinta Krumins, alltrials, vba
Zinta Krumins, the newly-appointed managing director of Boehringer Ingelheim UK and Ireland, has warned that the ‘devil is in the …
Deepak Khanna: the legacy of an outgoing ABPI president
March 31, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deepak Khanna, NHS, VBP, Whitehead, apbi, jonathan emms
You’d be forgiven for thinking that Deepak Khanna, the man who has overseen the activities of the ABPI for the …
NICE launches VBA consultation
March 27, 2014Sales and Marketing Dillon, England, NHS, NICE, VBP, catchpole, pars, vba
NICE has today launched its consultation into how value-based assessment of drugs will work in practice, which will run for …
PPRS deal ‘dreadful’, says EMIG
November 26, 2013Sales and Marketing EMIG, NHS, NICE, PPRS, VBP
The Ethical Medicines Industry Group (EMIG) has slammed the new PPRS plan, calling it a ‘dreadful deal’ for its members. …
NICE tells pharma: don’t blame us for rejections
November 18, 2013Sales and Marketing Dillon, NHS, NICE, VBP
The head of NICE has publicly defended his agency against more pharma criticism but admits that it can make changes …
Pharma slams PPRS deal
November 15, 2013Medical Communications, Sales and Marketing ABPI, PPRS, VBP, telegraph
The fallout from last week’s new drug pricing plan in the UK is continuing as nine pharma firms write an …
PPRS: thumbs-down from pharma
November 7, 2013Sales and Marketing ABPI, NHS, PPRS, Pfizer, VBP
A missed opportunity for patients, which creates financial problems for smaller companies while stifling life science investment – these are …
New UK drug pricing plans ‘delayed’
October 7, 2013Medical Communications, Sales and Marketing Drug pricing, Hunt, Lansley, NHS, NICE, VBP
Cancer Drugs Fund to run until 2016
September 30, 2013Research and Development, Sales and Marketing CDF, Cameron, NHS, NICE, VBP
England’s Cancer Drugs Fund will run until 2016 and be given a £400 million boost under plans announced by the …
Cancer Drugs Fund to stay, government to announce
September 27, 2013Medical Communications, Sales and Marketing CDF, Cameron, NHS, NICE, VBP, prime minister
The UK’s prime minister is set to announce that the controversial Cancer Drugs Fund will remain in place after March …
Latest content
FibroFind appoints Lee Borthwick as CEO
